Zynex Inc. (ZYXI)
| Bid | 1.91 |
| Market Cap | 58.94M |
| Revenue (ttm) | 172.4M |
| Net Income (ttm) | -7.41M |
| EPS (ttm) | -0.24 |
| PE Ratio (ttm) | -8.12 |
| Forward PE | -9.31 |
| Analyst | Hold |
| Ask | 1.99 |
| Volume | 513,107 |
| Avg. Volume (20D) | 283,327 |
| Open | 1.75 |
| Previous Close | 1.66 |
| Day's Range | 1.71 - 2.00 |
| 52-Week Range | 1.66 - 11.97 |
| Beta | 1.10 |
About ZYXI
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by fiel...
Analyst Forecast
According to 3 analyst ratings, the average rating for ZYXI stock is "Hold." The 12-month stock price forecast is $6, which is an increase of 207.69% from the latest price.
Stock ForecastsEarnings Surprise
21 hours ago · accessnewswire.com
Levi & Korsinsky Notifies Zynex, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ZYXINEW YORK, NY / ACCESS Newswire / April 30, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a potential recovery under the federal securities laws, fo...
